Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Date of authorisation: 27/04/2001, Revision: 35, Status: Authorised
MSSG Voluntary Solidarity Mechanism
Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, (Multi trial) substantial modification, non-substantial modification, and Request for information (RFI)
Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 4, Status: Authorised
Orphan designation: obinutuzumab Treatment of follicular lymphoma, 19/06/2015 Withdrawn
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 4-6 November 2025
Summary of opinion: Credelio, 06/11/2025 Positive
Summary of opinion: Frontpro (previously Afoxolaner Merial) Positive
Summary of opinion: Mhyosphere PCV ID, 06/11/2025 Positive